Nadine Anderson

Sr Scientist II & Protein Sciences Team Lead at GRO Biosciences

Nadine Anderson has a wealth of work experience in the biosciences field. Nadine began their career in 2013 as a Graduate Student Researcher at the Geisel School of Medicine at Dartmouth, where they defined cellular function and biochemical mechanism of a previously uncharacterized protein. Nadine published two first-author manuscripts and presented research at local and international conferences, and mentored junior graduate students regarding experimental design, technical execution, and science communication. In 2019, they became a Postdoctoral Researcher at the University of Massachusetts Medical School, where they determined genetic requirements for mitochondrial function and signaling in human cells through CRISPR-Cas9 mediated genome editing, transcriptional profiling, respirometry, and live cell imaging. Nadine also wrote, edited, and reviewed articles and grants, securing renewal of lab funding and expediting publication of high-quality manuscripts. In 2021, Nadine Anderson began working for Bristol Myers Squibb as a Scientist, where they supported setup, operation, and sampling of 5L fed-batch and perfusion bioreactor cultures of Chinese Hamster Ovary (CHO) cells expressing monoclonal antibodies and antibody fusion proteins. Nadine also executed high and medium throughput screens for cell line selection and culture optimization using a Tecan liquid handling robot and Ambr250 mini-bioreactor system. Additionally, they contributed to writing and editing of scientific manuscripts. Currently, Nadine Anderson is working as a Scientist II at GRO Biosciences, where they are advancing preclinical assets by designing and executing experiments, including protein expression, purification, conjugation, formulation, and analysis using FPLC, UV-Vis, UHPLC, and LC/MS. Nadine is also coordinating with external academic collaborators to enable cell culture and in vivo proof of concept studies.

Nadine Anderson attended the University of Minnesota-Morris from 2008 to 2012 and obtained a Bachelor of Arts in Biology, General. Nadine then attended the Geisel School of Medicine at Dartmouth from 2012 to 2019 and obtained a Doctor of Philosophy in Biochemistry and Molecular Biology in 2018. Additionally, they obtained a PhD certification from the Geisel School of Medicine at Dartmouth in November 2018.

Links

Previous companies

Bristol-Myers Squibb logo